Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan

Journal of Medical Virology

Volumn 78, Issue 1, 2006, Pages 18-23

  Lin, Jye Bin ^a,b   Lin, Ding Bang ^a,b   Chen, Shiuan Chih ^b   Chen, Pao San ^c   Chen, Wen Kang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

Author keywords

HAV versus HEV; HBV versus HCV; Preschool children; Seroprevalence; Transmission route

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ABORIGINE; AGE; ARTICLE; CONTROLLED STUDY; EDUCATION; ENDEMIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; KINDERGARTEN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARENTAL SCHOOLING; PRESCHOOL CHILD; QUESTIONNAIRE; RADIOIMMUNOASSAY; RISK FACTOR; RURAL AREA; SEROEPIDEMIOLOGY; SEROPREVALENCE; SERUM; SEX DIFFERENCE; TAIWAN; URBAN AREA; VIRUS HEPATITIS; VIRUS TRANSMISSION;

AGE FACTORS; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS C; HEPATITIS E; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; RADIOIMMUNOASSAY; RURAL POPULATION; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; TAIWAN; URBAN POPULATION;

HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS;

EID: 28944437346     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20517     Document Type: Article

References (43)

1. Chang MH, Le CY, Chen DS. 1993. Minimal role of hepatitis C infection in childhood liver disease in an area hyperendemic for hepatitis B infection. J Med Virol 40:322-325.
2. Chen DS. 1996. Viral hepatitis in East Asia. J Formosan Med Assoc 96:6-12.
3. Chen DS, Hsu NHM, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, Shih YT. 1987. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mother. JAMA 257:2597-2603.
4. Chen CJ, You CY, You SL, Lu CF, Hsu ST. 1990a. Seroepidemiology of hepatitis A, B and D viruses among children in Taiwan. In: Sung JL, Chen DS, editors. Viral hepatitis and hepatocellular carcinoma. Hong Kong: Excerpta Medica Asia Ltd. pp 9-15.
5. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M. 1990b. Hepatitis C virus infection in an area hyperendemic for hepatitis B chronic liver disease: The Taiwan experience. J Infect Dis 162:817-822.
6. Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantun D, Kaptue L, Chionne P, Conti S, Sarrechia B, Naccarato R. 1991. Hepatitis B virus in Cameroon: A seroepidemiological survey in city school children. J Med Virol 33:95-99.
7. Coursaget P, Bringer L, Sarr G, Bourdil C, Fritzell B, Blondeau C, Yvonnet B, Chiron JP, Jeannee E, Guindo S. 1992. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine 10:379-382.
8. Coursaget P, Buisson Y, Enogat N, Bercion R, Baudet JM, Delmaire P, Prigent D, Desrame J. 1998. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses. J Hepatol 28:745-750.
9. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. 1996. Higher seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in Nile Delta: A pilot study. Am J Trop Med Hyg 54:554-558.
10. Fan PC, Chang MH, Lee PI, Safary A, Lee CY. 1998. Follow-up immunogenicity of an inactivated hepatitis A virus vaccine in healthy children: Results after 5 years. Vaccine 16:232-235.
11. Hayashi J, Kashiwagi S, Kajiyama W, Ikematsu H, Nogochi A, Nomura H, Ikeda K. 1988. Comparison of results of recombinant and plasma-derived Hepatitis B vaccines in Japanese nursery-school children. J Infect 17:49-55.
12. Heintges T, Wands JR. 1997. Hepatitis C virus: Epidemiology and transmission. Hepatology 26:521-526.
13. Hohler T, Reuss E, Evera N, Dietrich E, Rittner C, Freitag CM, Vollmar J, Schneider PM, Fimmers R. 2002. Differential genetic determination of Immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: A vaccination study in twins. Lancet 360:991-995.
14. Hsieh SY, Yang PY, Ho YP, Chu CM, Liaw YF. 1998. Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan. J Med Virol 55:300-304.
15. Hsu LC, Lin SR, Hsu HM, Chao WH, Hsieh JT, Wang MC, Lu CF, Chang YH, Ho MS. 1996. Ethnic differences in immune responses to hepatitis B vaccine. Am J Epidemiol 143:718-724.
16. Just M, Berger R, Scheiermann N. 1988. Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine. Vaccine 6:401-402.
17. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumanki Y, Hatzakis A, Hseih CC, Hadziyannis SJ. 1991. Hepatitis B and C virusese and their interaction in the origin of hepatocellular carcinoma. JAMA 265:1974-1976.
18. Lee SD, Wand YJ, Lu RH, Chan CY, Lo KJ, Moeckli P. 1994. Seroprevalence of antibody to hepatitis E virus among Chinese subjects in Taiwan. Hepatology 19:866-870.
19. Li CP, Hwang SJ, Lu CL, Chan CY, WU JC, Lee FY, Lee SD. 1996. Risk factor analysis of patients with chronic hepatitis C in Taiwan. Chinese Med J 58:275-280.
20. Lin DB, Wang HM, Lee YL, Ling UP, Changlai SP, Chen CJ. 1998. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. Vaccine 16:1683-1687.
21. Lin DB, Tsai TP, Yang CC, Wang HM, Yuan SC, Cheng MH, You SL, Chen CJ. 2000a. Current seroprevalence of hepatitis A virus infection among kindergarten children and teachers in Taiwan. Southeast Asian J Trop Med Public Health 31:25-28.
22. Lin HH, Li YH, Yu JH, Wang YW, Lua AC, Huang LC, Huang SC, Lee ML. 2000b. Ethnic and Geographic variations in the prevalence of hepatitis A, B and C among aboriginal villages in Hualien, Taiwan. Infection 28:205-208.
23. Lin DB, Lin JB, Chen SC, Yang CC, Chen WK, Chen CJ. 2004. Seroepidemiology of hepatitis E virus infection among preschool children in Taiwan. J Med Virol 74:414-418.
24. Liu CC, Wang JY, Yao WJ. 1994. Seroepidemiology of hepatitis A virus infection Southern Taiwan. Acta Paediatr Sin 35:391-396.
25. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY. 2004. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40:1415-1420.
26. Martinson FEA, Weigle KA, Mushahwar IK, Weber DJ, Royce R, Lemon SM. 1996. Seroepidemiological survey of hepatitis B and C virus infection in Ghanaian children. J Med Virol 48:278-283.
27. Marx G, Martin SR, Chicoine JF, Alvarez F. 2002. Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. J Infect Dis 186:295-301.
28. McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. 2004. Racial and Ethnic differences in the seroprevalence of 6 infectious diseases in the United States: Data from NHANES III, 1988-1994. Am J Public Health 94:1952-1958.
29. Most J, Larcher C, Vogetseder W, Prodinger WM, Huemer HP, Ebenbichler CF, Dierich MP. 1992. Recombinant versus plasma-derived hepatitis B vaccine: Comparison of immunogenicity in medical students. Vaccine 10:740-741.
30. Sherman KE. 1991. Alanine aminotransferase in clinical practice: A review. Arch Intern Med 151:260-265.
31. Smalligan RD, Lange WR, Frame JD, Yarbough PO, Frankengield DL, Hyams KC. 1995. The risk of viral hepatitis A, B, C, and E among North American missionaries. Am J Trop Med Hyg 53:233-236.
32. Soyletir G, Bahceci E, Akoglu E, Soyogul U, Lawrance RA. 1992. Clinical evaluation of low dose intradermally administered hepatitis B vaccine: A comparison of plasma-derived and recombinant yeast-derived vaccines. Vaccine 10:301-304.
33. Stevens CE, Taylor PE, Tong MJ, Vyas GN, Nair PV, Weissman JY, Krugman S. 1987. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 257:2612-2616.
34. Su CW, Wu JC, Huang YS, Huo TI, Huang YH, Lin CC, Chang FY, Lee SD. 2002. Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan. J Gastroenterol Hepatol 17:1187-1191.
35. Sung JL, Chen DS, Lai MY, Yu JU, Wang TH, Wang CY, Lee CY, Chen SH, Ko TM. 1984. Epidemiology study on hepatitis B virus infection in Taiwan. Chinese J Gastroenterol 1:1-9.
36. Theal RM, Scott K. 1996. Evaluating asymptomatic patients with abnormal Liver function test results. Am Fam Physician 53:2111-2119.
37. Tsega E, Nordenfeldt E, Mengesha B, Hansson BG, Tsega M, Lindderg J. 1990. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis 22:145-148.
38. Tzeng GH, Wu TY. 1986. Characteristics of urbanizational level in Taiwan districts. Geogr Res 12:287-323.
39. Wang LY, Cheng YW, Chou SJ, Chen CJ. 1993. Secular trend and geographical variation in hepatitis A infection and hepatitis B carrier rate among adolescents in Taiwan: A island-wide survey. J Med Virol 39:1-5.
40. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. 2001. Change in hepatitis A virus seroepidemiology in southern Taiwan: A large percentage of the population lack protective antibody. J Med Virol 64:104-108.
41. Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, Hu HT. 1980. Hepatitis A virus infection in Taiwan. J Formosan Med Assoc 79:694-699.
42. Wu TC, Hsieh KS, Wang HC, Wong YL, Shiao IS, Kwan SH, Yeh SH. 1982. Seroepidemiology of hepatitis A infection in children in Taiwan. J Formosan Med Assoc 81:1012-1016.
43. Wu JS, Lu CF, Wu LZ, Wong CK, Wu YC, Lee TC, Chen KL, Chen HY. 1993. Changing seroepidemiology of hepatitis A virus infection between two regions in Taiwan differing in socioeconomic status. J Formosan Med Assoc 92:812-815.